NYSE:NGVT - Ingevity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $87.43 +1.17 (+1.36 %) (As of 05/26/2019 04:00 PM ET)Previous Close$87.43Today's Range$84.74 - $87.9852-Week Range$74.98 - $120.41Volume275,559 shsAverage Volume335,258 shsMarket Capitalization$3.66 billionP/E Ratio21.17Dividend YieldN/ABeta1.61 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process and caprolactone. This segment's products are used in various applications comprising pavement preservation, pavement adhesion promotion and warm mix paving, oil well service additives, oil production and downstream application chemicals, printing inks, adhesives, agrochemicals, lubricants and industrial intermediates, coatings resins, elastomers, adhesives, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina. Receive NGVT News and Ratings via Email Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A CIK1653477 Webhttp://www.ingevity.com/ Phone843-740-2300Debt Debt-to-Equity Ratio4.03 Current Ratio2.29 Quick Ratio1.14Price-To-Earnings Trailing P/E Ratio21.17 Forward P/E Ratio18.25 P/E Growth1.57 Sales & Book Value Annual Sales$1.13 billion Price / Sales3.23 Cash Flow$5.3638 per share Price / Cash Flow16.30 Book Value$8.57 per share Price / Book10.20Profitability EPS (Most Recent Fiscal Year)$4.13 Net Income$169.10 million Net Margins13.70% Return on Equity53.81% Return on Assets12.22%Miscellaneous Employees1,750 Outstanding Shares41,845,000Market Cap$3.66 billion Next Earnings Date7/24/2019 (Estimated) OptionableOptionable Ingevity (NYSE:NGVT) Frequently Asked Questions What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." How were Ingevity's earnings last quarter? Ingevity Corp (NYSE:NGVT) released its quarterly earnings results on Wednesday, May, 1st. The company reported $0.99 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.97 by $0.02. The company had revenue of $276.80 million for the quarter, compared to analysts' expectations of $288.07 million. Ingevity had a return on equity of 53.81% and a net margin of 13.70%. The business's revenue for the quarter was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 earnings per share. View Ingevity's Earnings History. When is Ingevity's next earnings date? Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Ingevity. What price target have analysts set for NGVT? 8 brokerages have issued 1-year price objectives for Ingevity's shares. Their forecasts range from $68.00 to $130.00. On average, they expect Ingevity's share price to reach $99.75 in the next year. This suggests a possible upside of 14.1% from the stock's current price. View Analyst Price Targets for Ingevity. What is the consensus analysts' recommendation for Ingevity? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity. Has Ingevity been receiving favorable news coverage? Media headlines about NGVT stock have been trending somewhat negative on Sunday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ingevity earned a news impact score of -1.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Ingevity's key competitors? Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), W. R. Grace & Co (GRA), Ashland Global (ASH), Huntsman (HUN), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Chemours (CC), Olin (OLN), Balchem (BCPC), PQ Group (PQG), Innospec (IOSP), GCP Applied Technologies (GCP), KMG Chemicals (KMG) and Nexeo Solutions (NXEO). What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include NVIDIA (NVDA), Paypal (PYPL), Citigroup (C), CVS Health (CVS), General Electric (GE), Quaker Chemical (KWR), Verizon Communications (VZ), Costco Wholesale (COST), Alphabet (GOOG) and IDEXX Laboratories (IDXX). Who are Ingevity's key executives? Ingevity's management team includes the folowing people: Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58) Who are Ingevity's major shareholders? Ingevity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.35%), Wells Fargo & Company MN (2.50%), Goldman Sachs Group Inc. (1.75%), FMR LLC (1.73%), Neuberger Berman Group LLC (1.67%) and Northern Trust Corp (1.66%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity. Which major investors are selling Ingevity stock? NGVT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Pictet Asset Management Ltd., Principal Financial Group Inc., OppenheimerFunds Inc., Kornitzer Capital Management Inc. KS, Mountaineer Partners Management LLC, Marshall Wace LLP and FMR LLC. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity. Which major investors are buying Ingevity stock? NGVT stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Columbus Circle Investors, Northern Trust Corp, American International Group Inc., Rice Hall James & Associates LLC, Redwood Investments LLC, The Manufacturers Life Insurance Company and JPMorgan Chase & Co.. View Insider Buying and Selling for Ingevity. How do I buy shares of Ingevity? Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $87.43. How big of a company is Ingevity? Ingevity has a market capitalization of $3.66 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe. What is Ingevity's official website? The official website for Ingevity is http://www.ingevity.com/. How can I contact Ingevity? Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected] MarketBeat Community Rating for Ingevity (NYSE NGVT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 265 (Vote Outperform)Underperform Votes: 251 (Vote Underperform)Total Votes: 516MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/26/2019 by MarketBeat.com StaffFeatured Article: Bear Market Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.